|
1. Grant Awards in Cycle XIX and XX |
|
|
1.1 Conventional ROTRF Research Grants - Cycle XIX |
|
Prof. Leszek Ignatowicz
Medical College of Georgia, Augusta, USA |
Origin and Allocation of Regulatory T cells upon Graft Rejection or Acceptance |
Prof. Victor Laubach
University of Virginia, Charlottesville, USA |
Prevention of Lung Transplant Injury by Adenosine Receptor Activation |
Dr Andrew Luster
Massachusetts General Hospital, Charlestown, USA |
Chemokine-Mediated Control of Effector and Regulatory T Cells in Lung Rejection |
Prof. Anette Melk
Medizinische Hochschule Hannover, Kinderklinik, Hannover, Germany |
Overcoming Senescence Mechanisms Will Lead to Better Renal Graft Survival |
Prof. Wei-Ping Min
University of Western Ontario, London, Canada |
Prevention of Organ Injury and Rejection in Transplantation |
Prof. Andrey Sorokin
Medical College of Wisconsin, Milwaukee, USA |
Prevention of Virus-associated Nephropathy after Renal Transplantation |
|
|
|
|
1.2 Conventional ROTRF Research Grants - Cycle XX |
|
Dr Ignacio Anegon
INSERM U643, Nantes, France |
Analysis of Cells That Inhibit Anti-graft Immune Responses |
Dr David Russell
University of Washington, Seattle, USA |
Histocompatible Stem Cells for Transplantation |
Dr Anna Valujskikh
Cleveland Clinic, Cleveland, USA |
Alloantibody Production in Sensitized Transplant Recipients |
Dr Barbara A. Wasowska
Johns Hopkins University, Baltimore, USA |
Sialylated IgG Antibodies Inhibit Inflammation and Graft Rejection |
|
|
|
|
1.3 Clinical ROTRF Research Grants - Cycle XIX |
|
Prof. Annette Boehler
University Hospital, Zurich, Switzerland |
Confocal Microscopy after Lung Transplantation: Specific Findings during Rejection? |
Dr Diana Metes
University of Pittsburgh, Pittsburgh, USA |
Immune Cells for Therapy of Post-transplant Lymphoproliferative Disorders in Pediatric Transplant Patients |
|
|
|
|
1.4 Clinical ROTRF Research Grants - Cycle XX |
|
Dr Neal N. Iwakoshi
Emory University, Atlanta, USA |
Transplant Rejection Mediated by Antibody |
Dr David Neujahr
Emory University, Atlanta, USA |
Predictive Modeling of Outcomes in Lung Transplantation |
Dr Emmanuel Zorn
Massachusetts General Hospital, Boston, USA |
Characterization of Immune Cells Contributing to the Rejection of Transplanted Kidneys in Humans |
|
|
|
|
2. ROTRF/JDRF Joint Grant Awards - Cycle XIX and XX |
|
|
2.1 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XIX |
|
Dr Karen Dwyer
St. Vincent’s Hospital, Melbourne, Australia |
Prolonging Pancreatic Islet Cell Survival following Transplantation |
|
|
|
|
2.2 Conventional ROTRF/JDRF Joint Grant Awards - Cycle XX |
|
Dr Jacques Thibodeau
University Montreal, Montreal, Canada |
New Immunological Avenues to Improve Allograft Survival |
|
|
|
|
2.3 Clinical ROTRF/JDRF Joint Grant Awards - Cycle XIX |
|
Mr Paul Johnson
University of Oxford, Oxford, UK |
Optimisation of Human Pancreatic Islet Isolation |